August 26, 2016

August 26, 2016

Moffitt Cancer Center Receives Two NCI Grants to Further Prostate Cancer, Biomarker Research
The ASCO Post – Aug. 25
Moffitt Cancer Center researchers David ­Basanta, PhD, and Conor Lynch, PhD, have been awarded a $3.2 million U01 grant to investigate prostate cancer metastasis. Prostate cancer frequently spreads to the bone and can cause painful bony lesions and increased mortality for patients.

Bone marrow vs Bloodstream: Stem cell source influences transplantation outcomes
Oncology Nurse Advisor – Aug. 25
“Results of this study set bone marrow as the standard source of stem cells for transplantation from unrelated donors,” said Claudio Anasetti, chair of the Department of Blood and Marrow Transplantation at Moffitt Cancer Center, and senior author of the study.

Alternatives to professorships in academia
Science Magazine – Aug. 25
Bolstered by her principal investigator, Latanya Scott started exploring the profession of technology transfer. Informational interviews with staff in this field led to an internship in Moffitt’s Office of Innovation and Industry Alliances, and ultimately a job offer as a licensing associate.

Accurate Risk Status Assessment Critical to Prostate Cancer Care
OncLive – Aug. 25
In a lecture at the 2016 OncLive State of the Science Summit on Genitourinary Cancers, Pow-Sang, MD, chair of Urological Oncology at Moffitt Cancer Center, discussed the significance of assessing risk status, options for patients whose risk status falls in a “grey-zone,” and how technology is helping oncologists more accurately characterize risk. 

Anything For Tyler: One Florida family risked everything to treat their son with medical marijuana
Tampa Bay Times – Aug. 25
“There’s not a lot of evidence that it works, right?” said Dr. Peter Forsyth, chair of neuro-oncology at Moffitt Cancer Center. “But the more accurate statement is it just hasn’t been investigated thoroughly and properly to make a decision about whether it works or not.”

Remembering Monsignor Higgins
Bay News 9 – Aug. 25
And serving here at Moffitt Cancer Center on the board for 2 decades. He dedicated his life to others,” said David de la Parte, Moffitt Cancer Center General Council.

Expert Discusses Novel Therapies, Biomarkers in mCRPC
OncLive – Aug. 24
In an interview with OncLive during the meeting, Zhang, a medial oncologist at Moffitt Cancer Center, discussed the key takeaways from his talk and his vision for treating patients with mCRPC. 

Allegany Ministries looks to boost life in Wimauma with $1 million
Tampa Bay Times – Aug. 24
Among those tapped to serve on the council was Moffitt Cancer Center outreach manager Venessa Rivera Colon. For the past eight years, Colon has overseen Moffitt's efforts to provide free breast cancer screenings for uninsured women in Wimauma.

Immunotherapy Advances Offer New Hope in Bladder Cancer
OncLive – Aug. 24
Michael Poch, MD, urologist and assistant member at Moffitt Cancer Center, discussed immunotherapy in the landscape of bladder cancer during a lecture at the 2016 OncLive State of the Science Summit on Genitourinary Cancers.

Monsignor Laurence Higgins, who built a parish and helped build Tampa, dies at 87
Tampa Bay Times – Aug. 24
He served on the boards of the H. Lee Moffitt Cancer Center & Research Institute Foundation, the Higgins Alcohol and Addiction Program at the University of South Florida's Institute for Research in Psychiatry, the Florida Treatment Center and many others.

Researchers Poised to Expand on Exciting Advancements in RCC
OncLive – Aug. 24
Fishman, a medical oncologist at Moffitt Cancer Center, highlighted the most recent advances in the field of RCC during his lecture at the 2016 OncLive State of the Science Summit on Genitourinary Cancers.

Well-known Tampa priest Tampa Monsignor Laurence Higgins dies at 87
WFLA – Aug. 24
His contributions to the community include serving on the board directors of the H. Lee Moffitt Cancer Center and Research Institute Foundation, Judeo Christian Health Clinic, "Higgins Alcohol and Addiction Program" at USF's Institute for Research in Psychiatry, Florida Treatment Center, Project Return, Gold Shield Foundation, MOSI, Crisis Center of Hillsborough County, Boys and Girls Clubs, Tampa and West Tampa Chambers of Commerce, Ybor City Development Corporation, the Outback Bowl, and many others.

Facing Uncertainty: Cancer Survivors With Chronic Pain
Clinical Oncology News – Aug. 23
David Craig, PharmD, the director of the pain and palliative care specialty residency at the H. Lee Moffitt Cancer Center and Research Institute, in Tampa, Fla., said he worries the new guidelines will raise barriers, however unintentionally, for cancer patients and survivors to access opioid medications.

Understanding the Rationale for Bone-Targeted Therapy in mCRPC
OncLive – Aug. 23
In an interview with OncLive during the meeting, Lynch, an associate professor of Tumor Biology at Moffitt Cancer Center, sheds light on the biology of bone metastases as well as the mechanism of action for bone-directed therapies.

Yearly low-dose CT lung cancer screening is important for those at high risk
Healthcare Business – Aug. 23
Patients who test negative for lung cancer using low-dose helical CT (LDCT) but later develop lung cancer within the next two years had worse outcomes than patients who initially had a non-cancerous finding. The results were from a Moffitt Cancer Center study that was recently published in PLOS One. 

Moffitt chosen to be site of cell therapy studies, latest treatment in cancer
83 Degrees Media – Aug. 23
"Until recently, cancer treatment options have been largely limited to radiation and chemotherapy,” says Linda L. Kelley, Ph.D., principal investigator and director of Moffitt’s Cell Therapy Facility. “Immunotherapy represents a paradigm shift in which the person’s own immune system is boosted to specifically target and kill tumor cells.”

A call for a new collaboration to cure Melanoma
Cancer Therapy Advisor – Aug. 22
“Newly diagnosed patients with unresectable, metastatic melanoma still need to participate in appropriate clinical trials. We're not quite at a place where every patient with a BRAF mutation will receive targeted therapy as his or her first and hopefully only treatment,” said co-author Vernon Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center, professor at oncologic sciences, and director of surgical education at the University of South Florida's College of Medicine in Tampa.

Chaos Theory: Understanding the Genetic Chaos of Soft Tissue Sarcoma
Cure Today – Aug. 22
“There are a whole bunch of DNA-damaging genetic mutations — a lot of chaos in many types of sarcoma,” says Damon Reed, director of the Adolescent and Young Adult Program and medical director of the Sarcoma Department at Moffitt Cancer Center in Tampa, Florida.

Why frequent lung cancer screenings are important to your health
Consumer Affairs – Aug. 22
A new study from the Moffitt Cancer Center in Tampa underlines the importance of screening for lung cancer – a disease that is a leading cause of death for both men and women. The researchers say that although treatment of the disease is complicated, proper screening allows healthcare professionals the ability to diagnose and treat it at its earliest stages.

Moffitt Cancer Center ranked on ‘Becker’s Hospital Review’
Tampa Patch – Aug. 22
Moffitt Cancer Center has once again been named to the 2016 edition of Becker’s Hospital Review's 100 Hospitals and Health Systems With Great Oncology Programs. Moffitt has appeared on every version of the list, featuring hospitals and health systems leading the nation in cancer care, since Becker’s Hospital Review began publishing it in 2012.

Psychological Effects From ADT a Growing Challenge in Prostate Cancer
OncLive – Aug. 22
In an interview with OncLive during the meeting, Heather Jim, MD., an associate member in the Health Outcomes and Behavioral Department at Moffitt Cancer Center, further described the psychological impacts of testosterone-lowering drugs for patients with prostate cancer—and what oncologists should do to help.

A call for a new collaboration to cure melanoma
Cancer Therapy Advisor – Aug. 22
“Newly diagnosed patients with unresectable, metastatic melanoma still need to participate in appropriate clinical trials. We're not quite at a place where every patient with a BRAF mutation will receive targeted therapy as his or her first and hopefully only treatment,” said co-author Vernon Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center, professor at oncologic sciences, and director of surgical education at the University of South Florida's College of Medicine in Tampa.

An emerging view of evolution is informing cancer research
Medical Xpress – Aug. 22
In cancer biology, the role of epigenetics is gaining acceptance, but it's still meeting resistance from researchers who may have spent a lifetime with the idea that cancer cells are primarily the result of individual mutations, said Alexander Anderson, PhD, chair of integrated mathematical oncology at the Moffitt Cancer Center, in Tampa, Florida.

Research in Florida finds benefits of meditation on cancer patients
WMFE – Aug. 20
Christine Healy, a clinical social worker at Moffitt, started the hospital’s program three years ago with coworker Sharen Lock, a yoga therapist.

Lung Cancers Detected On Screening CT Scans Have Better Survival
MedicalResearch.com – Aug. 19
“Our study is a post-hoc analysis of data from a large randomized clinical trial (RCT) called the National Lung Screening Trial (NLST). The NLST found that lung cancer screening with low-dose helical computed tomography (LDCT) significantly reduced lung cancer deaths by 20 percent compared to screening with standard chest radiography (i.e., X-Ray).” - Matthew B. Schabath PhD, Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute

Expert Offers Insight on Postoperative Radiation in Prostate Cancer
OncLive – Aug. 19
In an interview with OncLive during the 2016 OncLive State of the Science Summit on Genitourinary Cancers, Peter Johnstone, MD, Moffitt Cancer Center, provided insight on post-prostatectomy RT.

Parents Feel Better About HPV Shots For Preteens If They Can Opt Out
NPR.org – Aug. 19
"Now we have the chance to prevent cancer. This is a disease people care a lot about," says Anna Giuliano, director of the Center for Infection Research in Cancer at Moffitt Cancer Center in Tampa, and a researcher who led some of the HPV vaccine clinical trials. "We have a simple intervention to prevent cancer, but the message has gotten diluted and contorted by the general public that we don't need prevention interventions, whether it's to prevent measles or pertussis or HPV, so this is the struggle."

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.